Compounds > tingenone

Page last updated: 2024-08-26

tingenone and celastrol

tingenone has been researched along with celastrol in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (33.33)	18.2507
2000's	1 (16.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Farnsworth, NR; Ngassapa, O; Pezzuto, JM; Soejarto, DD	1
Chan, WK; Chang, MN; He, W; Huang, FC; Moriarty, KJ; Yu, KT; Zhang, DC; Zilberstein, A	1
Hirasawa, Y; Morita, H; Muto, A; Sekita, S; Shirota, O; Yoshida, T	1
Chang, JS; Kim, YM; Lee, JY; Lee, WS; Park, KH; Park, SJ; Rho, MC; Ryu, YB; Seo, WD	1
Brooks, WH; Chen, L; Daniel, KG; Guida, WC; Lawrence, HR; Lawrence, NJ; Scott, LM; Sebti, SM; Wu, J	1
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW	1

Other Studies

6 other study(ies) available for tingenone and celastrol

Article	Year
Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea. Journal of natural products, 1994, Volume: 57, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Humans; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Philippines; Plants, Medicinal; Triterpenes; Tumor Cells, Cultured	1994
Novel cytokine release inhibitors. Part I: Triterpenes. Bioorganic & medicinal chemistry letters, 1998, Jul-21, Volume: 8, Issue:14 Topics: Animals; Cytokines; Humans; In Vitro Techniques; Inflammation; Molecular Structure; Rats; Triterpenes	1998
Antimitotic quinoid triterpenes from Maytenus chuchuhuasca. Bioorganic & medicinal chemistry letters, 2008, Feb-01, Volume: 18, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Humans; Maytenus; Molecular Structure; Pentacyclic Triterpenes; Plants, Medicinal; Triterpenes; Tubulin	2008
SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii. Bioorganic & medicinal chemistry letters, 2010, Mar-15, Volume: 20, Issue:6 Topics: Antiviral Agents; Benzoquinones; Models, Molecular; Plant Extracts; Severe acute respiratory syndrome-related coronavirus; Tripterygium; Triterpenes	2010
Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs. Bioorganic & medicinal chemistry letters, 2011, Jan-15, Volume: 21, Issue:2 Topics: Antineoplastic Agents, Hormonal; Estramustine; Humans; Models, Molecular; Neoplasms; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Structure-Activity Relationship; Triterpenes	2011
Perspectives on SARS-CoV-2 Main Protease Inhibitors. Journal of medicinal chemistry, 2021, 12-09, Volume: 64, Issue:23 Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors	2021